Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLIVA calcipotriol + betamethasone ointment versus vehicle and Dovobet in plaque psoriasis
2010-023482-21Phase 3Completed
- Sponsor
- PLIVA
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcipotriol + betamethasone in plaque psoriasis (3 arms), sponsored by PLIVA. Primary endpoint: Percentage reduction in Modified PASI score from baseline to Week 5. Started Feb 2011; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2010-023482-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023482-21.